Sun.Dec 15, 2024

article thumbnail

Butchered bones suggest violent 'othering' of enemies in Bronze Age Britain

Science Daily: Pharmacology News

Analysis of the remains of at least 37 individuals from Early Bronze Age England finds they were killed, butchered, and probably consumed before being thrown down a 15m-deep shaft. It is the largest-scale example of interpersonal violence from British prehistory. The treatment of the remains was likely a means to dehumanize or 'other' the victims. This massacre was probably revenge for a perceived offense, implying a cycle of violence and questioning the idea that Early Bronze Age Britain was re

Treatment 254
article thumbnail

Drug Patent Expirations for the Week of December 15, 2024

Drug Patent Watch

REMODULIN (treprostinil) United therap Patent: 10,076,505 Expiration: Dec 16, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Avoiding Infinite Loops When Utilizing useEffect() in ReactJS

Perficient: Drug Development

useEffect in ReactJS The useEffect hook is widely used in React for handling side effects within functional components. However, a common concern associated with its usage is the risk of triggering infinite loops. In React functional components, the useEffect hook is employed to handle side effects, such as fetching data from an API or updating the DOM.

52
article thumbnail

FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What CMC Questions Did They Answer? (Part 2)

FDA Law Blog: Drug Discovery

By Richard A. Lewis, Senior Regulatory Device & Biologics Expert & James E. Valentine We recently published the first part of our review of FDAs draft guidance titled Frequently Asked Questions Developing Potential Cellular and Gene Therapy Products. Questions and Answers Guidance (see previous coverage here ). In this post we focus in on the draft guidance documents chemistry, manufacturing, and controls (CMC)-specific content.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Unlocking AI Power: Building Predictive Models with Ease With Model Builder

Perficient: Drug Development

What is Model Builder? Model Builder is a powerful tool within Salesforce’s Einstein One platform that empowers users to create and deploy custom machine learning models without requiring extensive coding knowledge. It simplifies the process of building predictive models, making AI accessible to a broader range of users. Benefits of Using Model Builder Accelerated Time to Value: Model Builder significantly reduces the time it takes to develop and deploy AI models.

52